Stockscreener 앱 받기
4.29
3.16%
-0.14
시간 외 거래:
4.05
-0.24
-5.59%
전일 마감가:
$4.43
열려 있는:
$4.2
하루 거래량:
144.49K
Relative Volume:
17.70
시가총액:
$5.54M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$4.18
$4.45
1주일 범위
$4.0001
$5.00
52주 변동 폭
$4.0001
$5.00
Applied Dna Sciences Inc Stock (BNBX) Company Profile
명칭
Applied Dna Sciences Inc
전화
631-240-8800
주소
50 HEALTH SCIENCES DRIVE, STONY BROOK
BNBX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNBX
Applied Dna Sciences Inc
|
4.29 | 5.72M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Applied Dna Sciences Inc Stock (BNBX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-02-12 | 개시 | ROTH Capital | Buy |
| 2021-01-14 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-18 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-02 | 개시 | H.C. Wainwright | Buy |
| 2016-11-14 | 재확인 | Maxim Group | Buy |
| 2016-05-13 | 재확인 | Maxim Group | Buy |
| 2015-10-08 | 재확인 | Maxim Group | Buy |
| 2015-05-26 | 개시 | The Benchmark Company | Speculative Buy |
| 2015-02-10 | 재확인 | Maxim Group | Buy |
| 2015-01-13 | 개시 | Maxim Group | Buy |
모두보기
Applied Dna Sciences Inc 주식(BNBX)의 최신 뉴스
Intraday pattern recognizer results for Applied DNA Sciences Inc.July 2025 Fed Impact & High Accuracy Investment Signals - newser.com
What’s next for Applied DNA Sciences Inc. stock priceWeekly Stock Summary & Weekly High Potential Alerts - newser.com
What MACD signals say about Applied DNA Sciences Inc.Portfolio Growth Summary & Long-Term Investment Growth Plans - newser.com
Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences - The Commercial Appeal
Applied DNA Sciences Announces New CEO Appointment - MSN
Applied DNA Sciences, Inc. will Change its Ticker to BNBX from APDN - MarketScreener
Applied DNA says on Sept 30 co implemented restructuring planSEC filing - MarketScreener
Applied DNA Sciences to Update Ticker Symbol to BNBX - GuruFocus
Applied DNA Sciences to change ticker symbol to BNBX - Investing.com
Applied DNA Sciences changes ticker to BNBX reflecting digital asset focus - Investing.com Nigeria
Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX’ Reflecting Digital Asset Treasury Strategy - MarketScreener
What analysts say about Applied DNA Sciences Inc stockPrice Gap Trading Strategies & Rapid Profit Growth - earlytimes.in
Applied DNA Sciences Announces Private Placement Offering - TipRanks
Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga
What drives Applied DNA Sciences Inc stock priceCandlestick Pattern Analysis & Minimize Portfolio Damage with Warnings - earlytimes.in
Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation - 01net
Applied DNA Launches $58 Million Private Placement in Pivot to Crypto Treasury - MarketScreener
Applied DNA Sciences secures up to $58 million for BNB treasury strategy - Investing.com
Applied DNA Sciences Inc announces private placement of up to $58 mln - MarketScreener
Applied DNA Sciences Inc Announces Private Placement Of Up To $58 Mln - TradingView
Full technical analysis of Applied DNA Sciences Inc. stockEarnings Performance Report & Weekly Setup with High ROI Potential - newser.com
Applied DNA Sciences, Inc. announced that it expects to receive $26.8 million in funding - MarketScreener
Applied DNA to present nucleic acid solutions at Boston conferences By Investing.com - Investing.com Canada
Breakthrough DNA Platform for mRNA and CAR-T: Applied DNA Presents at Two Major Industry Conferences - Stock Titan
BPAS - FinancialContent
Long Island gains two new women CEOs; gender gap persists - Newsday
Applied DNA Reports Third Quarter Fiscal 2025 Financial Results - ACCESS Newswire
Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application - ACCESS Newswire
Applied DNA Lands 7th Major Order as Global Cancer Diagnostic Maker Expands LineaDNA Usage - Stock Titan
Applied DNA Sciences regains Nasdaq compliance with $1 minimum bid By Investing.com - Investing.com Canada
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Applied DNA Sciences Announces Strategic Restructuring - TipRanks
Dr. James A. Hayward Retires from Applied DNA Sciences - Dentistry Today
Applied DNA Sciences names Judy Murrah as new chairperson and CEO - Investing.com
Applied DNA to Resume Quarterly Investor Call Cadence Beginning - GuruFocus
Applied DNA Sciences to change ticker symbol to BNBX By Investing.com - Investing.com Nigeria
Applied DNA Sciences Faces Nasdaq Delisting Hearing - TipRanks
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 - The Columbus Dispatch
APDN stock plunges to 52-week low of $0.32 amid market challenges - Investing.com Canada
Applied DNA Sets Reverse Stock Split for June 2, Moves Key Investor Call to June 17 - Stock Titan
APDN stock plunges to 52-week low of $0.62 amid market challenges - Investing.com
Applied DNA Sciences Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results - ACCESS Newswire
Applied DNA Announces Double Update: Q2 Earnings Plus Special Strategic Priorities Discussion - Stock Titan
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA - FinancialContent
Applied DNA Overcomes Delisting Threat: Successfully Maintains Nasdaq Standards - Stock Titan
APDN stock plunges to 52-week low at $1.14 amid steep decline - Investing.com
Growth or Bubble? APDN’s Unexpected Surge - timothysykes.com
APDN Stock Plummets: Opportunity or Warning? - timothysykes.com
Applied DNA Sciences Announces Major Share Consolidation to Maintain Nasdaq Listing - Stock Titan
Applied DNA abandons DNA authentication business - Anti-counterfeiting news
Applied Dna Sciences Inc (BNBX) 재무 분석
Applied Dna Sciences Inc (BNBX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.17%
2.19%
자본화:
|
볼륨(24시간):